Dutta S, Khedmatgozar H, Patel GK, Latour D, et al. A TBX2-driven signaling switch from androgen receptor to glucocorticoid receptor confers therapeutic resistance in prostate cancer. Oncogene 2024 Dec 20. doi: 10.1038/s41388-024-03252.
PMID: 39702503